Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana, Noella Umulisa, Meera Venkatesan, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 8, pp. 1120-1128
Open Access | Times Cited: 325

Showing 1-25 of 325 citing articles:

Evidence of Artemisinin-Resistant Malaria in Africa
Betty Balikagala, Naoyuki Fukuda, Mie Ikeda, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 13, pp. 1163-1171
Open Access | Times Cited: 625
Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness
Barbara H. Stokes, Satish K. Dhingra, Kelly Rubiano, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 133
Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda
Melissa D. Conrad, Victor Asua, Shreeya Garg, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 8, pp. 722-732
Open Access | Times Cited: 120
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
Selam Mihreteab, Lucien Platon, Araia Berhane, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 13, pp. 1191-1202
Open Access | Times Cited: 103
Antimalarial drug discovery: progress and approaches
Jair L. Siqueira-Neto, Kathryn J. Wicht, Kelly Chibale, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 807-826
Open Access | Times Cited: 93
Reflections on the 2021 World Malaria Report and the future of malaria control
April Monroe, Nana Aba Williams, Sheila B. Ogoma, et al.
Malaria Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 89
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
Patrick K. Tumwebaze, Melissa D. Conrad, Martin Okitwi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Plasmodium falciparum resistance to artemisinin-based combination therapies
Kurt E. Ward, David A. Fidock, Jessica L. Bridgford
Current Opinion in Microbiology (2022) Vol. 69, pp. 102193-102193
Open Access | Times Cited: 70
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa
Philip J. Rosenthal, Victor Asua, Melissa D. Conrad
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 373-384
Closed Access | Times Cited: 52
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
Tran Dang Nguyen, Bo Gao, Chanaki Amaratunga, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
The emergence of artemisinin partial resistance in Africa: how do we respond?
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. 1225-1233
Open Access | Times Cited: 22
Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021
Eric Rogier, Nastassia Battle, Catherine Bakari, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Resurgence of malaria and artemisinin resistance in Africa requires a concerted response
Nebiyu Dereje, Mosoka Fallah, Tamrat Shaweno, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 2
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination
Mehul Dhorda, Chanaki Amaratunga, Arjen M. Dondorp
Current Opinion in Infectious Diseases (2021) Vol. 34, Iss. 5, pp. 432-439
Open Access | Times Cited: 91
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
Leonard Ndwiga, Kelvin M. Kimenyi, Kevin Wamae, et al.
International Journal for Parasitology Drugs and Drug Resistance (2021) Vol. 16, pp. 155-161
Open Access | Times Cited: 79
Malaria in 2022: Increasing challenges, cautious optimism
Prasanna Jagannathan, Abel Kakuru
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria
E. Schmitt, Gilles Ndayisaba, Adoke Yeka, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 10, pp. 1831-1839
Open Access | Times Cited: 62
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Thomas J. Peto, Rupam Tripura, James J. Callery, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 867-878
Open Access | Times Cited: 48
Artemisinin resistance and malaria elimination: Where are we now?
Borimas Hanboonkunupakarn, Joel Tärning, Sasithon Pukrittayakamee, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis
Karol J. Marwa, Anthony Kapesa, Vito Baraka, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0264339-e0264339
Open Access | Times Cited: 39
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum
Krittikorn Kümpornsin, Theerarat Kochakarn, Tomas Yeo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania
Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 27
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
Robert Zupko, Tran Dang Nguyen, Jean Claude Semuto Ngabonziza, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2775-2784
Open Access | Times Cited: 25
Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia
Brook Jeang, Daibin Zhong, Ming‐Chieh Lee, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top